Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Investigate the Use of Alendronate to Reduce the Risk of Pelvic Insufficiency Fractures in Cervical Cancer Patients Treated With Chemotherapy and Radiation Therapy

NCT07245381 is registered in ClinicalTrials.gov with Dr. Itay GoorAryeh as lead sponsor.

NCT NCT07245381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07245381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Investigate the Use of Alendronate to Reduce the Risk of Pelvic Insufficiency Fractures in Cervical Cancer Patients Treated With Chemotherapy and Radiation Therapy
Lead sponsor
Dr. Itay GoorAryeh
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
September 30, 2026
Enrollment
65 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervix cancer